Clinical trial
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186329 |
|---|---|
| Title | BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) |
| Official title | B-type Natriuretic Peptide for Cardio-Renal Decompensation Syndrome |
| Lead sponsor | Stanford University, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure Exacerbation, Renal Insufficiency |
| Intervention type | Drug |
| Interventions | Natrecor, a recombinant form of B-type Natriuretic Peptide, made by Scios, Inc. vs. placebo |
| Enrollment | 100 |
| Start date | Mar 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: